CDXS

Conclusions

• 🔴Price vs. SMA 50 — Price is below the 50-day average
• 🔴Price vs. SMA 200 — Price is below the 200-day average
• 🔴Death Cross — SMA 50 recently crossed below SMA 200
• 🔴MACD — MACD histogram is negative — falling momentum
• 🔴RSI — RSI 28.2 — oversold
• 🔴Stochastic — %K 7.6 — oversold
• 🔴ADX (trend strength) — ADX 36.9 — strong trend
• 🔴Relative strength vs. S&P 500 — -52.0% over the last 3 months relative to the index
• 🔴Bollinger Bands — Price is in the lower third of the Bollinger Bands (22%B) — weakness (chance of a recovery)
• 🔴ROC (rate of change) — ROC 12 days: -34.4%
• 🔴Parabolic SAR — Price is below the SAR point — downtrend
• 🔴CMF (money flow) — CMF 20 days: -0.34

3️⃣ Suggested Exit Point (ATR-based)

Method formula: Stop-loss = resistance plusone ATR margin — this way the stop adapts to the stock's actual volatility, rather than an arbitrary number.

Profit Targets by Risk/Reward Ratio (R)

Conclusions

• 🟢Gross margin — Gross margin: 86.7% — strong
• 🔴Operating margin — Operating margin: -59.3% (negative)
• 🔴Net margin — Net margin: -62.5% (negative)
• 🔴Return on equity (ROE) — Return on equity (ROE): -87.0% (negative)
• 🔴Return on assets (ROA) — Return on assets (ROA): -29.8% — weak
• 🟢Current ratio (liquidity) — Current ratio: 3.82
• 🟡Debt-to-equity — Debt/equity: 0.79

Conclusions

• 🟢Revenue growth (last year) — Revenue growth (last year): 18.6%
• 🟢Earnings per share (EPS) growth — Earnings per share (EPS) growth: 43.8%
• 🟢Free cash flow growth — Free cash flow growth: 55.6%
• 🟢Net income growth — Net income growth: 32.6%

Conclusions

• 🔴DCF Fair Value — Estimated fair value: -$3.49 vs. price $1.48 (-336.0%)
• 🟡Tangible Net Asset Value (NAV) — NAV per share: $0.55
• 🟡P/E — P/E: -2.9